How much does GaoruiZhe (Golidocitinib Capsules) Cost& price without insurance in China?
GaoruiZhe® is the commercial brand name of Golidocitinib Capsules, an orally active JAK1 inhibitor developed by Dizal. It selectively inhibits Janus kinase 1 (JAK1), blocking JAK-STAT signaling pathways to suppress tumor cell proliferation and survival.
Main Indications
Treatment of adult patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) who have received at least one prior systemic therapy.
Common Side Effects
Common mild adverse reactions: Neutropenia, thrombocytopenia, anemia, diarrhea, and fatigue.
Laboratory abnormalities: Elevated liver enzymes, increased triglycerides, and decreased lymphocyte counts.
Severe but uncommon risks: Severe infections, pneumonitis, hepatotoxicity, and thromboembolic events.
Approval Status in China
GaoruiZhe® (Golidocitinib Capsules, 0.15g) was officially approved for marketing in China in 2024. It is currently a prescription anti-tumor drug.
Buy GaoruiZhe (Golidocitinib Capsules) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
